Insider transactions

EDGAR

GILEAD SCIENCES, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
88 transactions, 733,976 shares
Sum of shares × price per share: 108,886,727.1806

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 232

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-16 Filed 2026-11-17Mercier Johanna Officer: Chief Comm Corp Aff Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)25,00072.34
1,808,500

Derived: shares × price per share. Exact value 1808500.00.

138,684Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
Open filing 0001782135-26-000037 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Mercier Johanna Officer: Chief Comm Corp Aff Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)13,922169.9711
2,366,337.6542

Derived: shares × price per share. Exact value 2366337.6542.

124,762Direct (D) Yes
F1, F2
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
  • F2 Sale prices for the transactions reported range from $169.57 to $170.56. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001782135-26-000037 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Mercier Johanna Officer: Chief Comm Corp Aff Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)13,178171.0937
2,254,672.7786

Derived: shares × price per share. Exact value 2254672.7786.

111,584Direct (D) Yes
F1, F3
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
  • F3 Sale prices for the transactions reported range from $170.58 to $171.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001782135-26-000037 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Mercier Johanna Officer: Chief Comm Corp Aff Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)900171.6856
154,517.04

Derived: shares × price per share. Exact value 154517.0400.

110,684Direct (D) Yes
F1, F4
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
  • F4 Sale prices for the transactions reported range from $171.65 to $171.69. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001782135-26-000037 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Mercier Johanna Officer: Chief Comm Corp Aff Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Non-qualified Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 72.34
Disposed (D)25,0000—44,960Direct (D) Yes
F1, F5
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
  • F5 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Open filing 0001782135-26-000037 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17Dickinson Andrew D Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,000171.47
514,410

Derived: shares × price per share. Exact value 514410.00.

158,096Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
Open filing 0001310204-26-000033 Read from the filing’s XML Dispute this row
2026-11-12 Filed 2026-11-16Kramer Kelly A. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)10,37666.92
694,361.92

Derived: shares × price per share. Exact value 694361.92.

11,715Direct (D) Yes
F1
  • F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2026.
Open filing 0001629885-26-000008 Read from the filing’s XML Dispute this row
2026-11-12 Filed 2026-11-16Kramer Kelly A. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,676168.2255
281,945.938

Derived: shares × price per share. Exact value 281945.9380.

10,039Direct (D) Yes
F1, F2
  • F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2026.
  • F2 Sale prices for the transactions reported range from $167.95 to $168.88. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001629885-26-000008 Read from the filing’s XML Dispute this row
2026-11-12 Filed 2026-11-16Kramer Kelly A. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,800169.4423
643,880.74

Derived: shares × price per share. Exact value 643880.7400.

6,239Direct (D) Yes
F1, F3
  • F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2026.
  • F3 Sale prices for the transactions reported range from $169.04 to $169.90. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001629885-26-000008 Read from the filing’s XML Dispute this row
2026-11-12 Filed 2026-11-16Kramer Kelly A. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,700170.4941
801,322.27

Derived: shares × price per share. Exact value 801322.2700.

1,539Direct (D) Yes
F1, F4
  • F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2026.
  • F4 Sale prices for the transactions reported range from $170.08 to $171.01. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001629885-26-000008 Read from the filing’s XML Dispute this row
2026-11-12 Filed 2026-11-16Kramer Kelly A. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)200171.44
34,288

Derived: shares × price per share. Exact value 34288.00.

1,339Direct (D) Yes
F1
  • F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2026.
Open filing 0001629885-26-000008 Read from the filing’s XML Dispute this row
2026-11-12 Filed 2026-11-16Kramer Kelly A. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Non-qualified Stock Option (Right to Buy) — underlying Common Stock (10,376) — exercise price 66.92
Disposed (D)10,3760—0Direct (D) Yes
F1, F5
  • F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2026.
  • F5 25% of the shares subject to the option vested on each three-month anniversary measured from May 10, 2017 such that 100% of the shares subject to the option were fully vested and exercisable on May 10, 2018.
Open filing 0001629885-26-000008 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-09Cain Wettan Keeley M Officer: EVP Gen Counsel, Legal Comp
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,399164.11
557,809.89

Derived: shares × price per share. Exact value 557809.89.

5,360Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 07, 2026.
Open filing 0002110603-26-000015 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06O'Day Daniel Patrick Director · Officer: Chairman CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)9,81072.34
709,655.4

Derived: shares × price per share. Exact value 709655.40.

561,493Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
Open filing 0001638643-26-000040 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,810175.17
1,718,417.7

Derived: shares × price per share. Exact value 1718417.70.

551,683Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
Open filing 0001638643-26-000040 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06O'Day Daniel Patrick Director · Officer: Chairman CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Non-qualified Stock Option (Right to Buy) — underlying Common Stock (9,810) — exercise price 72.34
Disposed (D)9,8100—128,310Direct (D) Yes
F1, F3
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F3 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Open filing 0001638643-26-000040 Read from the filing’s XML Dispute this row
2026-11-04 Filed 2026-11-06O'Day Daniel Patrick Director · Officer: Chairman CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)102,61972.34
7,423,458.46

Derived: shares × price per share. Exact value 7423458.46.

654,302Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
Open filing 0001638643-26-000040 Read from the filing’s XML Dispute this row
2026-11-04 Filed 2026-11-06O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)102,619175.1627
17,975,021.1113

Derived: shares × price per share. Exact value 17975021.1113.

551,683Direct (D) Yes
F1, F2
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F2 Sale prices for the transactions reported range from $175.05 to $175.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001638643-26-000040 Read from the filing’s XML Dispute this row
2026-11-04 Filed 2026-11-06O'Day Daniel Patrick Director · Officer: Chairman CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Non-qualified Stock Option (Right to Buy) — underlying Common Stock (102,619) — exercise price 72.34
Disposed (D)102,6190—138,120Direct (D) Yes
F1, F3
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F3 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Open filing 0001638643-26-000040 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-02O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,600167.3999
267,839.84

Derived: shares × price per share. Exact value 267839.8400.

565,083Direct (D) Yes
F1, F3
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F3 Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001638643-26-000038 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-02O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,700168.1006
285,771.02

Derived: shares × price per share. Exact value 285771.0200.

563,383Direct (D) Yes
F1, F4
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F4 Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001638643-26-000038 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-02O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,904169.2733
322,296.3632

Derived: shares × price per share. Exact value 322296.3632.

561,479Direct (D) Yes
F1, F5
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F5 Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001638643-26-000038 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-02O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,796170.3527
1,328,069.6492

Derived: shares × price per share. Exact value 1328069.6492.

553,683Direct (D) Yes
F1, F6
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F6 Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001638643-26-000038 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-02O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,000171.0627
342,125.4

Derived: shares × price per share. Exact value 342125.4000.

551,683Direct (D) Yes
F1, F7
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F7 Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001638643-26-000038 Read from the filing’s XML Dispute this row
2026-10-30 Filed 2026-11-02O'Day Daniel Patrick Director · Officer: Chairman CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)15,88172.34
1,148,831.54

Derived: shares × price per share. Exact value 1148831.54.

582,564Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
Open filing 0001638643-26-000038 Read from the filing’s XML Dispute this row
2026-10-30 Filed 2026-11-02O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)15,881175.2456
2,783,075.3736

Derived: shares × price per share. Exact value 2783075.3736.

566,683Direct (D) Yes
F1, F2
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F2 Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001638643-26-000038 Read from the filing’s XML Dispute this row
2026-10-30 Filed 2026-11-02O'Day Daniel Patrick Director · Officer: Chairman CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Non-qualified Stock Option (Right to Buy) — underlying Common Stock (15,881) — exercise price 72.34
Disposed (D)15,8810—240,739Direct (D) Yes
F1, F8
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F8 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Open filing 0001638643-26-000038 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16Mercier Johanna Officer: Chief Comm Corp Aff Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,000156.22
468,660

Derived: shares × price per share. Exact value 468660.00.

113,684Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
Open filing 0001782135-26-000035 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16Dickinson Andrew D Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,000156.22
468,660

Derived: shares × price per share. Exact value 468660.00.

161,096Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
Open filing 0001310204-26-000031 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)12,000147.719
1,772,628

Derived: shares × price per share. Exact value 1772628.000.

569,683Direct (D) Yes
F1, F2
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F2 Sale prices for the transactions reported range from $147.21 to $148.205. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001638643-26-000035 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-02O'Day Daniel Patrick Director · Officer: Chairman CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,000148.6265
445,879.5

Derived: shares × price per share. Exact value 445879.5000.

566,683Direct (D) Yes
F1, F3
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • F3 Sale prices for the transactions reported range from $148.23 to $149.13. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001638643-26-000035 Read from the filing’s XML Dispute this row
2026-09-22 Filed 2026-09-23Burkhart Erin Officer: SVP, Controllership
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,223——2,223Direct (D) No
F1
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Open filing 0001927648-26-000005 Read from the filing’s XML Dispute this row
2026-09-22 Filed 2026-09-23Burkhart Erin Officer: SVP, Controllership
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)768152.67
117,250.56

Derived: shares × price per share. Exact value 117250.56.

1,455Direct (D) No— Open filing 0001927648-26-000005 Read from the filing’s XML Dispute this row
2026-09-22 Filed 2026-09-23Burkhart Erin Officer: SVP, Controllership
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (2,223)
Disposed (D)2,223——9,022Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • F2 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Open filing 0001927648-26-000005 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-16Mercier Johanna Officer: Chief Comm Corp Aff Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,600143.6917
229,906.72

Derived: shares × price per share. Exact value 229906.7200.

118,084Direct (D) Yes
F1, F2
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
  • F2 Sale prices for the transactions reported range from $143.16 to $144.15. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001782135-26-000033 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-16Mercier Johanna Officer: Chief Comm Corp Aff Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)800144.4569
115,565.52

Derived: shares × price per share. Exact value 115565.5200.

117,284Direct (D) Yes
F1, F3
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
  • F3 Sale prices for the transactions reported range from $144.26 to $144.775. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Open filing 0001782135-26-000033 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-16Mercier Johanna Officer: Chief Comm Corp Aff Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)600145.29
87,174

Derived: shares × price per share. Exact value 87174.00.

116,684Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
Open filing 0001782135-26-000033 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-16Dickinson Andrew D Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,000145.29
435,870

Derived: shares × price per share. Exact value 435870.00.

164,096Direct (D) Yes
F1
  • F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
Open filing 0001310204-26-000029 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11O'Day Daniel Patrick Director · Officer: Chairman CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)8,780——585,913Direct (D) No
F1
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Open filing 0001638643-26-000033 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11O'Day Daniel Patrick Director · Officer: Chairman CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)4,230144.81
612,546.3

Derived: shares × price per share. Exact value 612546.30.

581,683Direct (D) No— Open filing 0001638643-26-000033 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11O'Day Daniel Patrick Director · Officer: Chairman CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (8,780)
Disposed (D)8,780——83,300Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • F2 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Open filing 0001638643-26-000033 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Cain Wettan Keeley M Officer: EVP Gen Counsel, Legal Comp
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)590——9,044Direct (D) No
F1
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Open filing 0002110603-26-000013 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Cain Wettan Keeley M Officer: EVP Gen Counsel, Legal Comp
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)285144.81
41,270.85

Derived: shares × price per share. Exact value 41270.85.

8,759Direct (D) No— Open filing 0002110603-26-000013 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Cain Wettan Keeley M Officer: EVP Gen Counsel, Legal Comp
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (590)
Disposed (D)590——13,405Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • F2 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Open filing 0002110603-26-000013 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Mercier Johanna Officer: Chief Comm Corp Aff Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,797——121,031Direct (D) No
F1
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Open filing 0001782135-26-000031 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Mercier Johanna Officer: Chief Comm Corp Aff Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,347144.81
195,059.07

Derived: shares × price per share. Exact value 195059.07.

119,684Direct (D) No— Open filing 0001782135-26-000031 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Mercier Johanna Officer: Chief Comm Corp Aff Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (2,797)
Disposed (D)2,797——25,054Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • F2 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Open filing 0001782135-26-000031 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Berger Dietmar Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)533——19,785Direct (D) No
F1
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Open filing 0001739515-26-000011 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Berger Dietmar Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)263144.81
38,085.03

Derived: shares × price per share. Exact value 38085.03.

19,522Direct (D) No— Open filing 0001739515-26-000011 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Berger Dietmar Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (533)
Disposed (D)533——46,395Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • F2 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Open filing 0001739515-26-000011 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 2,457

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager125,246,865 SH18,668,045,217 dollarsHigher by 3,402,757 Prior quarter: 121,844,108Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 81,175,627 SH12,099,227,204 dollarsHigher by 83,893 Prior quarter: 81,091,734Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager60,954,967 SH9,085,337,831 dollarsLower by 261,585 Prior quarter: 61,216,552Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
FMR LLC Partly reported under another manager58,265,696 SH8,684,501,953 dollarsLower by 8,605,120 Prior quarter: 66,870,816Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Invesco Ltd. Partly reported under another manager38,662,436 SH5,762,636,028 dollarsLower by 1,156,715 Prior quarter: 39,819,151Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Capital World Investors Partly reported under another manager35,929,833 SH5,355,872,692 dollarsLower by 5,059,142 Prior quarter: 40,988,975Open filing 0001422849-26-000169 Filed 2026-11-12 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 35,685,818 SH5,318,971,173 dollarsHigher by 369,650 Prior quarter: 35,316,168Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager30,190,640 SH4,485,711,723 dollarsHigher by 124,998 Prior quarter: 30,065,642Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager27,664,121 SH4,123,338 dollarsLower by 2,332,573 Prior quarter: 29,996,694Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
Capital Research Global Investors Partly reported under another manager23,980,766 SH3,574,341,919 dollarsHigher by 4,587,470 Prior quarter: 19,393,296Open filing 0001422848-26-000129 Filed 2026-11-12 Dispute this row
MORGAN STANLEY Partly reported under another manager23,755,334 SH3,540,733,033 dollarsLower by 249,020 Prior quarter: 24,004,354Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager23,069,989 SH3,490,028,358 dollarsHigher by 2,249,368 Prior quarter: 20,820,621Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
Dodge Cox 21,800,593 SH3,249,378,387 dollarsLower by 1,876,974 Prior quarter: 23,677,567Open filing 0001193125-26-460252 Filed 2026-11-13 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager19,235,762 SH2,867,090,344 dollarsHigher by 586,697 Prior quarter: 18,649,065Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager14,756,244 SH2,199,418,241 dollarsLower by 507,685 Prior quarter: 15,263,929Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager14,599,708 SH2,176,086,471 dollarsHigher by 3,821,414 Prior quarter: 10,778,294Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager13,728,685 SH2,046,260,501 dollarsLower by 99,325 Prior quarter: 13,828,010Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager12,629,605 SH1,882,442,626 dollarsLower by 356,986 Prior quarter: 12,986,591Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager12,224,488 SH1,822,059,937 dollarsLower by 475,195 Prior quarter: 12,699,683Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Partly reported under another manager11,461,347 SH1,765,949,503 dollarsHigher by 4,809,514 Prior quarter: 6,651,833Open filing 0000912938-26-001073 Filed 2026-11-12 Dispute this row
Amundi Partly reported under another manager11,259,657 SH1,678,251,875 dollarsHigher by 1,487,219 Prior quarter: 9,772,438Open filing 0001172661-26-004884 Filed 2026-11-06 Dispute this row
Legal General Group Plc Partly reported under another manager10,400,312 SH1,550,166,499 dollarsLower by 20,819 Prior quarter: 10,421,131Open filing 0001495115-26-000075 Filed 2026-11-16 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager9,613,980 SH1,432,963,720 dollarsHigher by 2,344,810 Prior quarter: 7,269,170Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 8,278,210 SH1,233,867,201 dollarsHigher by 122,929 Prior quarter: 8,155,281Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager7,799,464 SH1,162,634,058 dollarsLower by 100,330 Prior quarter: 7,899,794Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager7,571,572 SH1,128,827,406 dollarsLower by 46,510 Prior quarter: 7,618,082Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager7,081,773 SH1,055,538,283 dollarsLower by 1,255,157 Prior quarter: 8,336,930Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
VANGUARD FIDUCIARY TRUST CO 7,000,294 SH1,043,393,821 dollarsHigher by 28,267 Prior quarter: 6,972,027Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Boston Partners Partly reported under another manager6,523,864 SH970,367,385 dollarsHigher by 505,906 Prior quarter: 6,017,958Open filing 0001386060-26-000054 Filed 2026-11-10 Dispute this row
WELLS FARGO COMPANY/MN Partly reported under another manager6,338,079 SH944,690,644 dollarsLower by 101,507 Prior quarter: 6,439,586Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager6,016,218 SH896,717,694 dollarsHigher by 2,056,949 Prior quarter: 3,959,269Open filing 0000748054-26-000009 Filed 2026-11-20 Dispute this row
Janus Henderson Group Ltd. Partly reported under another manager5,578,105 SH831,408,444 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager5,466,187 SH814,736,000 dollarsHigher by 969,337 Prior quarter: 4,496,850Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
NORDEA INVESTMENT MANAGEMENT AB Partly reported under another manager5,334,829 SH802,384,956 dollarsHigher by 182,590 Prior quarter: 5,152,239Open filing 0001218210-26-000023 Filed 2026-11-09 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager5,064,470 SH754,930,687 dollarsHigher by 451,087 Prior quarter: 4,613,383Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Partly reported under another manager4,627,685 SH689,775,884 dollarsHigher by 688,911 Prior quarter: 3,938,774Open filing 0001520354-26-000046 Filed 2026-11-13 Dispute this row
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. Partly reported under another manager3,899,466 SH581,123,760 dollarsHigher by 130,673 Prior quarter: 3,768,793Open filing 0000905148-26-004861 Filed 2026-11-16 Dispute this row
BANK OF MONTREAL /CAN/ Partly reported under another manager3,836,942 SH571,896,138 dollarsHigher by 64,514 Prior quarter: 3,772,428Open filing 0000927971-26-000111 Filed 2026-11-09 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager3,590,890 SH626,561,568 dollarsHigher by 100,610 Prior quarter: 3,490,280Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
Robeco Institutional Asset Management B.V. Partly reported under another manager3,442,819 SH513,152,173 dollarsLower by 17,074 Prior quarter: 3,459,893Open filing 0001418773-26-000004 Filed 2026-10-20 Dispute this row
HSBC HOLDINGS PLC Partly reported under another manager3,409,919 SH509,058,259 dollarsLower by 426,570 Prior quarter: 3,836,489Open filing 0000873630-26-000005 Filed 2026-11-16 Dispute this row
Swiss National Bank 3,395,900 SH506,158,895 dollarsLower by 104,800 Prior quarter: 3,500,700Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row
Mitsubishi UFJ Asset Management Co., Ltd. Partly reported under another manager3,346,451 SH498,788,522 dollarsHigher by 189,058 Prior quarter: 3,157,393Open filing 0001193125-26-447983 Filed 2026-11-05 Dispute this row
UBS Group AG Partly reported under another manager3,263,857 SH486,477,886 dollarsLower by 1,239,437 Prior quarter: 4,503,294Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
California Public Employees Retirement System 3,202,999 SH477,407,001 dollarsHigher by 412,410 Prior quarter: 2,790,589Open filing 0000919079-26-000013 Filed 2026-11-16 Dispute this row
BARCLAYS PLC Partly reported under another manager3,141,208 SH468,197,054 dollarsLower by 1,972,034 Prior quarter: 5,113,242Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Man Group plc Partly reported under another manager3,105,031 SH462,804,871 dollarsHigher by 1,869,835 Prior quarter: 1,235,196Open filing 0001637460-26-000004 Filed 2026-11-16 Dispute this row
National Pension Service 3,081,344 SH459,274,323 dollarsHigher by 18,951 Prior quarter: 3,062,393Open filing 0001193125-26-456954 Filed 2026-11-12 Dispute this row
FIRST TRUST ADVISORS LP Partly reported under another manager3,065,019 SH456,841,090 dollarsHigher by 73,386 Prior quarter: 2,991,633Open filing 0001445546-26-008622 Filed 2026-11-12 Dispute this row
VANGUARD ASSET MANAGEMENT, Ltd 3,023,731 SH450,687,106 dollarsHigher by 206,970 Prior quarter: 2,816,761Open filing 0001680208-26-000018 Filed 2026-11-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • NORGES BANK 21,965,555 SH
  • Sixth Street Partners Management Company, L.P. 8,155,281 SH
  • SG Americas Securities, LLC 4,780,493 SH
  • Jupiter Topco LLC 3,546,841 SH
  • Pacer Advisors, Inc. 3,110,000 SH
  • Point72 Asset Management, L.P. 1,437,685 SH
  • Caption Management, LLC 1,347,600 SH
  • NewEdge Wealth, LLC 754,019 SH
  • SG Americas Securities, LLC 522,300 SH
  • RNC CAPITAL MANAGEMENT LLC 356,290 SH
  • Sofinnova Investments, Inc. 343,100 SH
  • Jones Hill Capital LP 343,043 SH
  • Tredje AP-fonden 321,765 SH
  • Catalio Capital Management, LP 269,309 SH
  • Arbejdsmarkedets Tillaegspension 215,800 SH
  • Polaris Capital Management, LLC 153,300 SH
  • PICTON MAHONEY ASSET MANAGEMENT 119,118 SH
  • Arkadios Wealth Advisors 104,200 SH
  • Caption Management, LLC 100,000 SH
  • Thomasville National Bank 91,822 SH
  • PFM Health Sciences, LP 90,858 SH
  • Envestnet Portfolio Solutions, Inc. 86,812 SH
  • SPIREPOINT PRIVATE CLIENT, LLC 81,278 SH
  • DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. 80,000 SH
  • KEYSTONE INVESTORS PTE LTD 75,116 SH
  • UNITED BANK 61,418 SH
  • Twin Lakes Capital Management, LLC 58,267 SH
  • CAISSE DES DEPOTS ET CONSIGNATIONS 57,303 SH
  • Y-Intercept (Hong Kong) Ltd 57,007 SH
  • NatWest Group plc 49,485 SH
  • Quantitative Investment Management, LLC 44,223 SH
  • Summit Trail Advisors, LLC 43,955 SH
  • ADAPT Investment Managers SA 38,365 SH
  • ROWLANDMILLER PARTNERS.ADV 36,350 SH
  • CenterBook Partners LP 32,767 SH
  • Capricorn Fund Managers Ltd 31,200 SH
  • Mubadala Investment Co PJSC 29,623 SH
  • Wahed Invest LLC 29,566 SH
  • Atom Investors LP 29,028 SH
  • World Investment Advisors 28,563 SH
  • HSBC HOLDINGS PLC 27,000 SH
  • LOCKHEED MARTIN INVESTMENT MANAGEMENT CO 24,100 SH
  • D. E. Shaw Co., Inc. 21,600 SH
  • Arete Wealth Advisors, LLC 20,212 SH
  • Avidity Partners Management LP 20,000 SH
  • VCI Wealth Management LLC 19,805 SH
  • Northwest Bancshares, Inc. 19,719 SH
  • Whitaker-Myers Wealth Managers, LTD. 18,284 SH
  • Twin Tree Management, LP 18,000 SH
  • BAMCO INC /NY/ 18,000 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–50 of 89

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Jared Moskowitz (FL23)2026-05-06Purchase$1,001 - $15,000DC2026-06-19
Hon. Jared Moskowitz (FL23)2026-05-06Purchase$1,001 - $15,0002026-06-19
Hon. Josh Gottheimer (NJ05)2026-01-27Purchase$1,001 - $15,000JT2026-02-26
Hon. Valerie Hoyle (OR04)2025-09-23Sale$1,001 - $15,000SP2025-10-10
Hon. Valerie Hoyle (OR04)2024-10-29Purchase$1,001 - $15,000SP2025-09-12
Hon. Jefferson Shreve (IN06)2025-05-12Sale$15,001 - $50,0002025-06-22
Hon. Marjorie Taylor Greene (GA14)2025-06-06Purchase$1,001 - $15,0002025-06-18
Hon. Josh Gottheimer (NJ05)2025-05-14Sale$1,001 - $15,000JT2025-06-11
Hon. Marjorie Taylor Greene (GA14)2025-05-05Purchase$1,001 - $15,0002025-05-06
Hon. Marjorie Taylor Greene (GA14)2025-05-05Purchase$1,001 - $15,0002025-05-06
Hon. Jefferson Shreve (IN06)2025-03-31Purchase$15,001 - $50,0002025-04-11
Hon. Carol Devine Miller (WV01)2025-03-10Purchase$1,001 - $15,0002025-04-11
Hon. Josh Gottheimer (NJ05)2025-03-07Purchase$1,001 - $15,000JT2025-04-10
Hon. Marjorie Taylor Mrs Greene (GA14)2024-12-24Purchase$1,001 - $15,0002024-12-27
Hon. Greg Stanton (AZ04)2023-09-26Purchase$1,001 - $15,000SP2023-11-09
Hon. Greg Stanton (AZ04)2023-10-24Sale$1,001 - $15,000SP2023-11-09
Hon. Daniel Goldman (NY10)2023-07-12Sale$15,001 - $50,0002023-08-13
Hon. Zoe Lofgren (CA18)2023-05-25Sale$1,001 - $15,000SP2023-06-06
Hon. Daniel Goldman (NY10)2023-03-06Purchase$15,001 - $50,0002023-04-17
Hon. Zoe Lofgren (CA19)2022-09-09Purchase$1,001 - $15,000SP2022-10-11
Hon. Carol Devine Miller (WV03)2021-11-10Sale (partial)$15,001 - $50,000SP2022-09-02
Hon. Sara Jacobs (CA53)2021-04-09Sale$15,001 - $50,0002021-05-28
Mrs. Marjorie Taylor Greene (GA14)2021-01-21Purchase$1,001 - $15,000JT2021-02-19
Hon. Gilbert Cisneros (CA39)2020-12-22Sale$1,001 - $15,0002021-01-11
Hon. Dean Phillips (MN03)2020-12-18Sale (partial)$1,001 - $15,0002021-01-09
Hon. Ed Perlmutter (CO07)2020-09-01Sale (partial)$1,001 - $15,000SP2020-11-11
Hon. Dean Phillips (MN03)2020-09-23Purchase$1,001 - $15,0002020-10-09
Hon. Ed Perlmutter (CO07)2020-07-15Purchase$1,001 - $15,000SP2020-09-29
Hon. William R. Timmons IV (SC04)2020-06-29Sale$1,001 - $15,000SP2020-08-07
Hon. Roger W. Marshall (KS01)2020-05-05Purchase$1,001 - $15,000DC2020-06-03
Hon. Roger W. Marshall (KS01)2020-05-04Purchase$1,001 - $15,000DC2020-06-03
Hon. Roger W. Marshall (KS01)2020-05-07Purchase$1,001 - $15,000DC2020-06-03
Hon. Gilbert Cisneros (CA39)2020-03-18Purchase$1,001 - $15,0002020-04-16
Hon. Mikie Sherrill (NJ11)2020-02-20Sale$1,001 - $15,0002020-04-05
Hon. Gilbert Cisneros (CA39)2020-02-07Purchase$1,001 - $15,0002020-03-10
Hon. Mikie Sherrill (NJ11)2020-01-21Purchase$1,001 - $15,0002020-02-19
Hon. Mikie Sherrill (NJ11)2019-12-18Sale$1,001 - $15,0002020-01-10
Hon. Earl Blumenauer (OR03)2019-10-25Purchase$1,001 - $15,0002019-11-13
Hon. Bill Flores (TX17)2019-09-19Purchase$1,001 - $15,0002019-10-07
Hon. Dean Phillips (MN03)2019-05-13Sale (partial)$1,001 - $15,0002019-06-13
Hon. Bill Flores (TX17)2019-05-08Sale$1,001 - $15,0002019-06-13
Hon. Mikie Sherrill (NJ11)2019-04-18Sale$1,001 - $15,0002019-05-15
Hon. Bill Flores (TX17)2019-03-25Purchase$1,001 - $15,0002019-04-04
Hon. Dean Phillips (MN03)2019-01-04Sale (partial)$1,001 - $15,0002019-02-18
Hon. Greg Gianforte (MT00)2018-12-21Purchase$15,001 - $50,0002019-01-23
Hon. John A. Yarmuth (KY03)2018-11-26Sale$1,001 - $15,0002018-12-27
Hon. Gary Palmer (AL06)2017-04-04Purchase$1,001 - $15,000SP2018-09-29
Hon. John Rutherford (FL04)2017-07-17Purchase$1,001 - $15,0002018-08-20
Hon. Earl Blumenauer (OR03)2018-07-17Purchase$1,001 - $15,0002018-08-15
Hon. Josh Gottheimer (NJ05)2017-04-17Sale$1,001 - $15,000JT2018-08-13

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Vanguard Capital Management Common Stock7.5193,327,12703/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100119-26-000510 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 10Open filing 0000102909-26-001398 Dispute this row
FMR LLC COMMON STOCK5.365,539,476.7512/31/2025 Filed 2026-02-05SCHEDULE 13GOpen filing 0000315066-26-000432 Dispute this row
Abigail P. Johnson COMMON STOCK5.365,539,476.7512/31/2025 Filed 2026-02-05SCHEDULE 13GOpen filing 0000315066-26-000432 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,722,084 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015138,466
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to GILEAD SCIENCES, INC.